veracity glp 1 Unverified GLP-1-Related Claims Flood Food, Supplement Markets M&R
Description
Rigas, T
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) : These conditions involve hepatic inflammation and are closely linked to metabolic syndrome
Its not uncommon for these compounded alternatives to appear on ones screen when searching for weight loss treatment options
Patent number: US10278961B2, CN108997332B, US20230138576A1
Some researchers use GLP-1 medications for a defined period to reach their goal weight, then taper off while maintaining lifestyle changes
